Skip to main content

PAINESD Score for Assessing Hemodynamic Instability

 

PAINESD Score for Assessing Hemodynamic Instability Risk in Ventricular Tachycardia Ablation

Introduction


Catheter ablation for ventricular tachycardia (VT) can precipitate acute hemodynamic decompensation (AHD), particularly in patients with severe structural heart disease. To predict this risk before the procedure, the PAINESD score was developed. It is a validated clinical risk score used to estimate the likelihood of periprocedural hemodynamic instability during VT ablation and helps guide decisions regarding mechanical circulatory support (MCS) such as Impella or ECMO.



---


Components of the PAINESD Score


PAINESD is an acronym derived from the key predictors of hemodynamic compromise.


Parameter Points


P – Pulmonary disease (COPD) 5

A – Age > 60 years 3

I – Ischemic cardiomyopathy 6

N – NYHA Class III or IV heart failure 6

E – Ejection Fraction < 25% 3

S – VT Storm 5

D – Diabetes Mellitus 3



Maximum possible score: 31 points



---


Risk Stratification


PAINESD Score Risk of Acute Hemodynamic Decompensation


≤8 Low risk

9–14 Intermediate risk

≥15 High risk



Patients with high PAINESD scores have a significantly increased likelihood of intra-procedural hemodynamic collapse.



---


Clinical Significance


1. Predicts periprocedural hemodynamic collapse



2. Helps identify patients who may benefit from prophylactic mechanical circulatory support



3. Improves procedural planning and risk stratification



4. Associated with long-term mortality outcomes




Studies have shown that patients with high PAINESD scores have higher mortality and procedural complications, emphasizing the importance of pre-procedural risk assessment.



---


Role in VT Ablation Strategy


In patients with high PAINESD scores, clinicians may consider:


• Prophylactic mechanical support (Impella, ECMO, TandemHeart)

• Performing ablation under controlled hemodynamic support

• Limiting prolonged VT induction

• Optimizing heart failure status before procedure


This approach can significantly reduce periprocedural instability and improve procedural success.



---


Key Takeaways


• PAINESD score predicts risk of hemodynamic collapse during VT ablation

• Based on 7 clinical variables

• Score ≥15 indicates high risk

• Guides decision regarding prophylactic mechanical circulatory support



---


Conclusion


The PAINESD score is a practical and valuable tool for pre-procedural risk stratification in ventricular tachycardia ablation. By identifying patients at risk for acute hemodynamic decompensation, it helps clinicians plan safer procedures and determine the need for mechanical circulatory support, ultimately improving patient outcomes.

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...